Dugan Patricia, Carlson Chad, Jetté Nathalie, Wiebe Samuel, Bunch Marjorie, Kuzniecky Ruben, French Jacqueline
Department of Neurology, New York University Langone Medical Center, New York, New York, U.S.A.
Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.
Epilepsia. 2017 May;58(5):792-800. doi: 10.1111/epi.13730. Epub 2017 Apr 4.
Presently, there is no simple method at initial presentation for identifying a patient's likelihood of progressing to surgery and a favorable outcome. The Epilepsy Surgery Grading Scale (ESGS) is a three-tier empirically derived mathematical scale with five categories: magnetic resonance imaging (MRI), electroencephalography (EEG), concordance (between MRI and EEG), semiology, and IQ designed to stratify patients with drug-resistant focal epilepsy based on their likelihood of proceeding to resective epilepsy surgery and achieving seizure freedom.
In this cross-sectional study, we abstracted data from the charts of all patients admitted to the New York University Langone Medical Center (NYULMC) for presurgical evaluation or presented in surgical multidisciplinary conference (MDC) at the NYU Comprehensive Epilepsy Center (CEC) from 1/1/2007 to 7/31/2008 with focal epilepsy, who met minimal criteria for treatment resistance. We classified patients into ESGS Grade 1 (most favorable), Grade 2 (intermediate), and Grade 3 (least favorable candidates). Three cohorts were evaluated: all patients, patients presented in MDC, and patients who had resective surgery. The primary outcome measure was proceeding to surgery and seizure freedom.
Four hundred seven patients met eligibility criteria; 200 (49.1%) were presented in MDC and 113 (27.8%) underwent surgery. A significant difference was observed between Grades 1 and 3, Grades 1 and 2, and Grades 2 and 3 for all presurgical patients, and those presented in MDC, with Grade 1 patients having the highest likelihood of both having surgery and becoming seizure-free. There was no difference between Grades 1 and 2 among patients who had resective surgery.
These results demonstrate that by systematically using basic information available during initial assessment, patients with drug-resistant epilepsy may be successfully stratified into clinically meaningful groups with varied prognosis. The ESGS may improve communication, facilitate decision making and early referral to a CEC, and allow patients and physicians to better manage expectations.
目前,在初次就诊时,尚无简单方法可确定患者进展至手术及获得良好预后的可能性。癫痫手术分级量表(ESGS)是一种基于经验得出的三级数学量表,包含五个类别:磁共振成像(MRI)、脑电图(EEG)、一致性(MRI与EEG之间)、癫痫发作症状学及智商,旨在根据耐药性局灶性癫痫患者进行切除性癫痫手术并实现无癫痫发作的可能性对其进行分层。
在这项横断面研究中,我们从2007年1月1日至2008年7月31日入住纽约大学朗格尼医学中心(NYULMC)进行术前评估或在纽约大学综合癫痫中心(CEC)的手术多学科会议(MDC)上就诊的所有局灶性癫痫患者的病历中提取数据,这些患者符合最低治疗耐药标准。我们将患者分为ESGS 1级(最有利)、2级(中等)和3级(最不利候选者)。评估了三个队列:所有患者、在MDC就诊的患者以及接受了切除性手术的患者。主要结局指标是进行手术及无癫痫发作。
407例患者符合入选标准;200例(49.1%)在MDC就诊,113例(27.8%)接受了手术。对于所有术前患者以及在MDC就诊的患者,1级与3级之间、1级与2级之间以及2级与3级之间均观察到显著差异,1级患者进行手术和实现无癫痫发作的可能性最高。接受切除性手术的患者中,1级与2级之间无差异。
这些结果表明,通过系统地使用初次评估时可用的基本信息,耐药性癫痫患者可成功分层为具有不同预后的临床有意义的组。ESGS可能改善沟通、促进决策制定以及早期转诊至CEC,并使患者和医生能够更好地管理预期。